-
2020 End-of-Year Tribute: Interpretation of Important Research Results in the Field of Aging!
Time of Update: 2021-01-20
Now, in a new study, researchers from the Federal Institute of Technology in Lausanne, Switzerland, have revealed how these molecules target specific parts of the chromosome--- a finding that may help better understand the processes that regulate cell survival in aging and cancer, the study was published recently in the journal Nature.
-
Alzheimer's (AD) is a breakthrough drug! AXS-05 (right methafin/aphetamine release agent) enters Phase 3 clinical!
Time of Update: 2021-01-20
recently, the company announced the launch of the ACCORD (Assessment of Clinical Outcomes of Alzheimer's Disease) study, a randomized, double-blind, placebo-controlled Phase 3 study that will evaluate the efficacy and safety of AXS-05 (right methafin/aphetamine release agent) for the treatment of Alzheimer's disease (AD).
-
Chinese scientists have revealed that oxytocin can affect emotional behavior by projecting fibers in the brain
Time of Update: 2021-01-19
The team analyzed the three-dimensional fine structure and central function of the hylandostalin-neuropulbinal endocrine system (HNS), and the study revealed that oxytocin does not only act as a hormone by releasing it to the outer week, but can also affect our emotional behavior by projecting it into the emotional regulatory region of the brain.
-
Menopause: How dietary fiber regulates depression?
Time of Update: 2021-01-19
study also found that this may be associated with a reduced risk of depression, especially in pre-menotinal women.
study confirmed a negative correlation between dietary fiber intake and depression in pre-menotinal women after adjusting for other variables, but there was no significant difference between post-menoanth women.
-
Tourism Analysis: Traveling regularly may increase the overall well-being of your body to make you happier!
Time of Update: 2021-01-19
a study to explain why some people travel more frequently than others and whether travel experiences have a lasting impact on their body's well-being and health, said Chun-Chu, a researcher at the University of Hong Kong.
-
Cell sub-magazine puzzle: Why does "shake" make you sleep better?
Time of Update: 2021-01-19
, it turns out that lying on a bed that shakes gently makes it easier for people to fall asleep.
to understand this mystery, the researchers used fruit flies to build a model system to study vibration-induced sleep mechanisms.
-
PNAS: Effects of self-control in childhood
Time of Update: 2021-01-19
January 7, 2020 // -- An international team of researchers has found a link between self-control in childhood and success later in life.
paper published in PNAS, the team describes decades of research into children's self-control and their relationship to outcomes later in life.
-
Scientists have found that a positive attitude can help slow memory decline
Time of Update: 2021-01-19
researchers analyzed the relationship between positive emotions and memory loss, including age, gender, education level, depression, negative emotions, and found that memory declined with age.
study found that positive effects in middle-aged and older people were associated with memory loss with age, and that people with higher positive emotions had less memory loss.
-
Nature: Regulates the neural circuits of the brain that move finely
Time of Update: 2021-01-19
brain-dry circuit map reveals which neurons control the fine motor skills of the arms and hands.
" is controlled by latRM neurons that connect with neurons in other brain throe regions to perform more complex fore limb movements (including fingers), i.e. grab or feed food into the mouth.
-
JAHA: Relationship between D-D-djubo levels and all-cause death and adverse functional outcomes in patients with ischemic stroke or transient cerebral ischemic episodes
Time of Update: 2021-01-18
results showed that higher baseline and 90-day D-polymer levels were associated with adverse outcomes in patients with ischemic stroke or transient ischemic episodes.
-
Annals of Neurology: With people with Parkinson's disease with low body dystension, kabaratin improves cognitive function
Time of Update: 2021-01-18
the main significance of this study was the discovery that kabalatin had greater cognitive benefits for patients with OH-accompanied PDD, perhaps by improving the effects of hypotension.
Rivastigmine in Parkinson's Disease Dementia with Orthostatic Hypotension.
-
Lancet respir med: Reducing sedatives of benzodiazepines and increased visitation can reduce the risk of delirium in patients with severe neo-coronary pneumonia
Time of Update: 2021-01-18
2088 patients with severe neo-coronary pneumonia treated with ICU participated in the study, with an average age of 64 years, with an average SAPS II score of 40.0,1397 (66.9%) who had a mechanical agency on the day of ICU admission, and 1827 (87.5%) who had a mechanical angness during their hospitalization.
-
Can children benefit from mindth training?
Time of Update: 2021-01-18
I believe that mindthing and meditation may be particularly beneficial for children and adolescents because these skills may enhance brain circuits, which can control attention, concentrate and regulate emotions, and that childhood and ad age are key stages in the maturation of these neural loops.
-
Lancet Neurology: Safety and effective with placebo short-term prevention of plexual plexual headaches: a multi-center, double-blind, randomized controlled trial
Time of Update: 2021-01-18
all patients were given oral Verapami for long-term prevention, starting at 40 mg three times a day and increasing to 120 mg three times a day on the 19th day; the main endpoint of the study was the average number of headache attacks in the first week of Pernisson's treatment compared to a placebo.
-
JAHA: The significance of the strengthening of the intracranial aneurysm wall without rupture
Time of Update: 2021-01-18
researchers assessed the macro and micro characteristics of unbromed intracranial aneurysms that were associated with or not enhanced.
, however, the underlying pathological mechanisms of AWE still need further study.
-
JAMA Oncology: Frequency and influence of opioid use in cancer patients
Time of Update: 2021-01-18
results of the multivariable model showed that marital status (single, HR=1.58; divorce, HR=1.43), SOAPP score (positive and negative, HR=1.35), morphine daily dose (MEDD) (HR=1.003) and Edmonton symptom assessment scale pain level (HR=1.11) were independently associated with the presence of NMOU behavior.
-
Falkieri Treatment of Biplex Depression: Phase II Clinically Positive Results
Time of Update: 2021-01-18
this is a multi-center study of 88 adult patients with double-blind, placebo-controlled patients who did not respond well to evidence-based treatment for at least two biplent depressions.
were assigned 24 mg, 36 mg or 48 mg Falkieri or placebo twice a week for two weeks.
-
Science Translational Medicine: 1 g can poison millions of people, the world's strongest poison botulinum toxin, there is an antidote!
Time of Update: 2021-01-18
Using this method, the team successfully saved mice, guinea pigs and monkeys from botulinum toxin poisoning, which, if equally effective in humans, would be the first drug to reverse the effects of endotoxin paralysis, eliminating the need for ventilators to survive.
-
Annals of Neurology: Atrial fibrillation is pre-oral anticoagulant, which helps reduce the severity of stroke and improves thrombosis prognosis
Time of Update: 2021-01-18
Meinel of the University of Bern and others explored the relationship between early anticoagulant (VKA) or direct oral anticoagulant (DOACs) and stroke severity, venous thrombosis (IVT) use, IVT safety, and 3-month prognosis in patients with atrial fibrillation and acute ischemic stroke.
-
FDA awards MC-1 "orphan drug title" for treatment of phosphate sterol (amine) oxidase (PNPO) deficiency
Time of Update: 2021-01-18
addition, the European Medicines Agency (EMA) has awarded MC-1 the title of rare pediatric disease for the treatment of seizures associated with PNPO deficiency.
